Journal of Antimicrobial Chemotherapy (2000) 46, 223-228
© 2000 The British Society for Antimicrobial Chemotherapy
Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in The Netherlands
a National Institute of Public Health and the Environment, PO Box 1, 3720 BA Bilthoven and Public Health Laboratories at b Enschede, c Tilburg, d Rotterdam, e Goes and f Nijmegen, The Netherlands
In continuous surveillance of routine samples from five Dutch laboratories, we studied resistance to the antibiotics most commonly prescribed for urinary tract infections (UTI) in The Netherlands, namely norfloxacin, amoxycillin, trimethoprim and nitrofurantoin, from 1989 to 1998 in >90000 Escherichia coli isolates. Resistance to norfloxacin increased from 1.3% in 1989 to 5.8% in 1998. Multiresistance, defined as resistance to norfloxacin and at least two of the other three antibiotics, increased from 0.5% in 1989 to 4.0% in 1998. Multivariate analysis of the norfloxacin resistance demonstrated that this yearly increase (the odds ratio was 1.0 in 1989, 1.6 in 1992, 2.9 in 1995 and 6.1 in 1998) was independent of other determinants of resistance to norfloxacin, such as age, gender and origin of the isolate. Analysis of strata, classified by year, age and gender, demonstrated an association between prescription of fluoroquinolones (defined daily doses per case of UTI) and resistance to norfloxacin in E. coli (P < 0.001). There was no significant association with the prescription of nitrofuran derivatives (nitrofurantoin) and trimethoprim with or without sulphamethoxazole. The yearly increase of resistance to fluoroquinolones in E. coli from UTI may stem from increased prescription of fluoroquinolones for UTI. Resistance of E. coli to these agents is likely to increase further as fluoroquinolone use increases in future.
* Corresponding author. Tel: +31-30-2743865; Fax: +31-30-2744409; E-mail: wim.goettsch{at}rivm.nl
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Allou, E. Cambau, L. Massias, F. Chau, and B. Fantin Impact of Low-Level Resistance to Fluoroquinolones Due to qnrA1 and qnrS1 Genes or a gyrA Mutation on Ciprofloxacin Bactericidal Activity in a Murine Model of Escherichia coli Urinary Tract Infection Antimicrob. Agents Chemother., October 1, 2009; 53(10): 4292 - 4297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bergman, S. T. Nyberg, P. Huovinen, P. Paakkari, A. J. Hakanen, and and the Finnish Study Group for Antimicrobial Resi Association between Antimicrobial Consumption and Resistance in Escherichia coli Antimicrob. Agents Chemother., March 1, 2009; 53(3): 912 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Yagci, F. Yoruk, A. Azap, and O. Memikoglu Prevalence and Risk Factors for Selection of Quinolone-Resistant Escherichia coli Strains in Fecal Flora of Patients Receiving Quinolone Therapy Antimicrob. Agents Chemother., March 1, 2009; 53(3): 1287 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. De Backer, T. Christiaens, S. Heytens, A. De Sutter, E. E. Stobberingh, and G. Verschraegen Evolution of bacterial susceptibility pattern of Escherichia coli in uncomplicated urinary tract infections in a country with high antibiotic consumption: a comparison of two surveys with a 10 year interval J. Antimicrob. Chemother., August 1, 2008; 62(2): 364 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Gupta, T. M. Hooton, P. L. Roberts, and W. E. Stamm Short-Course Nitrofurantoin for the Treatment of Acute Uncomplicated Cystitis in Women Arch Intern Med, November 12, 2007; 167(20): 2207 - 2212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Lockhart, M. A. Abramson, S. E. Beekmann, G. Gallagher, S. Riedel, D. J. Diekema, J. P. Quinn, and G. V. Doern Antimicrobial Resistance among Gram-Negative Bacilli Causing Infections in Intensive Care Unit Patients in the United States between 1993 and 2004 J. Clin. Microbiol., October 1, 2007; 45(10): 3352 - 3359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Uzunovic-Kamberovic Antibiotic resistance of coliform organisms from community-acquired urinary tract infections in Zenica-Doboj Canton, Bosnia and Herzegovina J. Antimicrob. Chemother., August 1, 2006; 58(2): 344 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nys, T. van Merode, A. I. M. Bartelds, and E. E. Stobberingh Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture J. Antimicrob. Chemother., May 1, 2006; 57(5): 955 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Johnson, B. Johnston, M. A. Kuskowski, R. Colodner, and R. Raz Spontaneous Conversion to Quinolone and Fluoroquinolone Resistance among Wild-Type Escherichia coli Isolates in Relation to Phylogenetic Background and Virulence Genotype Antimicrob. Agents Chemother., November 1, 2005; 49(11): 4739 - 4744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Arslan, O. K. Azap, O. Ergonul, F. Timurkaynak, and on behalf of the Urinary Tract Infection Study Gro Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey J. Antimicrob. Chemother., November 1, 2005; 56(5): 914 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Landgren, H. Oden, I. Kuhn, A. Osterlund, and G. Kahlmeter Diversity among 2481 Escherichia coli from women with community-acquired lower urinary tract infections in 17 countries J. Antimicrob. Chemother., June 1, 2005; 55(6): 928 - 937. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Johnson, M. A. Kuskowski, T. T. O'Bryan, R. Colodner, and R. Raz Virulence Genotype and Phylogenetic Origin in Relation to Antibiotic Resistance Profile among Escherichia coli Urine Sample Isolates from Israeli Women with Acute Uncomplicated Cystitis Antimicrob. Agents Chemother., January 1, 2005; 49(1): 26 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sommet, C. Sermet, P. Y. Boelle, M. Tafflet, C. Bernede, and D. Guillemot No significant decrease in antibiotic use from 1992 to 2000, in the French community J. Antimicrob. Chemother., August 1, 2004; 54(2): 524 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kahlmeter, P. Menday, and O. Cars Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection J. Antimicrob. Chemother., December 1, 2003; 52(6): 1005 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Komp Lindgren, A. Karlsson, and D. Hughes Mutation Rate and Evolution of Fluoroquinolone Resistance in Escherichia coli Isolates from Patients with Urinary Tract Infections Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3222 - 3232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kahlmeter and P. Menday Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO{middle dot}SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections J. Antimicrob. Chemother., July 1, 2003; 52(1): 128 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Metlay, B. L. Strom, and D. A. Asch Prior antimicrobial drug exposure: a risk factor for trimethoprim-sulfamethoxazole-resistant urinary tract infections J. Antimicrob. Chemother., April 1, 2003; 51(4): 963 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kavatha, H. Giamarellou, Z. Alexiou, N. Vlachogiannis, S. Pentea, T. Gozadinos, G. Poulakou, A. Hatzipapas, and G. Koratzanis Cefpodoxime-Proxetil versus Trimethoprim-Sulfamethoxazole for Short-Term Therapy of Uncomplicated Acute Cystitis in Women Antimicrob. Agents Chemother., March 1, 2003; 47(3): 897 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kahlmeter An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO{middle dot}SENS Project J. Antimicrob. Chemother., January 1, 2003; 51(1): 69 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Oteo, J. Campos, F. Baquero, and Spanish members of the European Antimicrobial Resi Antibiotic resistance in 1962 invasive isolates of Escherichia coli in 27 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2001) J. Antimicrob. Chemother., December 1, 2002; 50(6): 945 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Karlowsky, L. J. Kelly, C. Thornsberry, M. E. Jones, and D. F. Sahm Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States Antimicrob. Agents Chemother., August 1, 2002; 46(8): 2540 - 2545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Z. Qiang, T. Qin, W. Fu, W. P. Cheng, Y. S. Li, and G. Yi Use of a rapid mismatch PCR method to detect gyrA and parC mutations in ciprofloxacin-resistant clinical isolates of Escherichia coli J. Antimicrob. Chemother., March 1, 2002; 49(3): 549 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. McDonald, F.-J. Chen, H.-J. Lo, H.-C. Yin, P.-L. Lu, C.-H. Huang, P. Chen, T.-L. Lauderdale, and M. Ho Emergence of Reduced Susceptibility and Resistance to Fluoroquinolones in Escherichia coli in Taiwan and Contributions of Distinct Selective Pressures Antimicrob. Agents Chemother., November 1, 2001; 45(11): 3084 - 3091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. de Neeling, B. P. Overbeek, A. M. Horrevorts, E. E. J. Ligtvoet, and W. G. Goettsch Antibiotic use and resistance of Streptococcus pneumoniae in The Netherlands during the period 1994-1999 J. Antimicrob. Chemother., September 1, 2001; 48(3): 441 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. van den Bogaard, N. London, C. Driessen, and E. E. Stobberingh Antibiotic resistance of faecal Escherichia coli in poultry, poultry farmers and poultry slaughterers J. Antimicrob. Chemother., June 1, 2001; 47(6): 763 - 771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Bertrand and D. Talon In vitro activity of co-amoxiclav acid against clinical isolates of Escherichia coli J. Antimicrob. Chemother., May 1, 2001; 47(5): 725 - 726. [Full Text] [PDF]
|
|
|
|
|
|
M. Cizman, A. Orazem, V. Krizan-Hergouth, and J. Kolman Correlation between increased consumption of fluoroquinolones in outpatients and resistance of Escherichia coli from urinary tract infections J. Antimicrob. Chemother., April 1, 2001; 47(4): 502 - 502. [Full Text] [PDF]
|
|